Current
Neuro-Oncology


Volume 20 Number 10
31 October 2018


Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 10, 31 October






Kenyon J, Liu W, Dalgleish A.
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol.
Anticancer Res. 2018 Oct 1, 2018;38(10):5831-5835. doi: 10.21873/anticanres.12924. PMID: 30275207. Observational study. ˍ




Youssef I, Lee A, Garay EL, Becker DJ, Schreiber D.
Patterns of care and outcomes of postoperative radiation for low-grade gliomas in United States hospitals.
J Clin Neurosci. 2018 Oct 1, 2018;58:124-129. doi: 10.1016/j.jocn.2018.09.010. PMID: 30287250 ˍ. Observational study. ˍ




Bräutigam E, Lampl C, Track C, Nieder C, Pichler J, Hammer J, Geinitz H.
Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.
Clin Transl Oncol. 2018 Oct 3, 2019;21(5):582-587. doi: 10.1007/s12094-018-1957-6. PMID: 30284233. Observational study. ˍ




Muracciole X, El-Amine W, Tabouret E, Boucekine M, Barlier A, Petrirena G, Harivony T, Solignac L, Chinot OL, Macagno N, Figarella-Branger D, Padovani L.
Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population.
Front Oncol. 2018 Oct 4, 2018;8:426. doi: 10.3389/fonc.2018.00426. PMID: 30338243. Observational study. ˍ




Syed M, Liermann J, Verma V, Bernhardt D, Bougatf N, Paul A, Rieken S, Debus J, Adeberg S.
Survival and recurrence patterns of multifocal glioblastoma after radiation therapy.
Cancer Manag Res. 2018 Oct 4, 2018;10:4229-4235. doi: 10.2147/CMAR.S165956. PMID: 30323678. Observational study. ˍ




Buchroithner J, Erhart F, Pichler J, Widhalm G, Preusser M, Stockhammer G, Nowosielski M, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Hoffermann M, Ruckser R, Rössler K, Spiegl-Kreinecker S, Fischer MB, Czech T, Visus C, Krumpl G, Felzmann T, Marosi C.
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Cancers (Basel). 2018 Oct 5, 2018;10(10):372. doi: 10.3390/cancers10100372. PMID: 30301187. Interventional study. ˍ




Achey RL, Gittleman H, Schroer J, Khanna V, Kruchko C, Barnholtz-Sloan JS.
Non-malignant and malignant meningioma incidence and survival in the elderly from 2005-2015 using the Central Brain Tumor Registry of the United States.
Neuro Oncol. 2018 Oct 6, 2019;21(3):380-391. doi: 10.1093/neuonc/noy162. PMID: 30295804. Observational study. ˍ




Ibbett I, Schembri G, Cook R, Parkinson J.
Role of 18F-fluoro-ethyl-tyrosine Positron Emission Tomography in Investigation and Management of Suspected Gliomas.
World Neurosurg. 2018 Oct 6, 2019;121:e712-e715. doi: 10.1016/j.wneu.2018.09.194. PMID: 30300714. Observational study. ˍ




Sirven-Villaros L, Bourg V, Suissa L, Mondot L, Almairac F, Fontaine D, Paquis P, Burel-VandenBos F, Frenay M, Thomas P, Lebrun-Frenay C.
Bevacizumab: Is the lower the better for glioblastoma patients in progression?
Bull Cancer. 2018 Oct 6, 2018;105(12):1135-1146. doi: 10.1016/j.bulcan.2018.07.010. PMID: 30301554. Interventional study. ˍ




Byun YH, Gwak HS, Kwon JW, Song MK, Shin SH, Jo YH, Yoo H, Lee SH.
Local recurrence of brain metastasis reduced by intra-operative hyperthermia treatment.
Int J Hyperthermia. 2018 Oct 8, 2019;35(1):168-175. doi: 10.1080/02656736.2018.1488004. PMID: 30293465. Interventional study. ˍ




Peckham ME, Osborn AG, Palmer CA, Tsai A, Salzman KL.
Gliosarcoma: Neuroimaging and Immunohistochemical Findings.
J Neuroimaging. 2018 Oct 8, 2019;29(1):126-132. doi: 10.1111/jon.12565. PMID: 30295979. Observational study. ˍ




Wang J, Zhang Y, Sun H, Cui R.
Hypermetabolism Caused by Seizure Mimicking Tumor Recurrence.
Clin Nucl Med. 2018 Oct 8, 2018;43(12):930-932. doi: 10.1097/RLU.0000000000002305. PMID: 30300207. Case report. ˍ




Terziev R, Petrirena G, Marie Y, Mueller WC, Bielle F, Delattre JY.
Posterior fossa recurrence of WHO grade II and III supratentorial gliomas.
Rev Neurol (Paris). 2018 Oct 9, 2018;174(10):705-710. doi: 10.1016/j.neurol.2017.10.018. PMID: 30314742. Observational study. ˍ




Byun J, Kim YH, Nam SJ, Park JE, Cho YH, Kim HS, Hong SH, Kim JH, Kim SJ, Kim CJ.
Comparison of Survival Outcomes Between Partial Resection and Biopsy for Primary Glioblastoma: A Propensity Score-Matched Study.
World Neurosurg. 2018 Oct 11, 2019;121:e858-e866. doi: 10.1016/j.wneu.2018.09.237. PMID: 30315970. Observational study. ˍ



*

D'Alessandris QG, Montano N, Martini M, Cenci T, Lauretti L, Stumpo V, Pignotti F, Olivi A, Fernandez E, Larocca LM, Pallini R.
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report.
Acta Neurochir (Wien). 2018 Oct 11, 2018;160(12):2387-2391. doi: 10.1007/s00701-018-3697-3. PMID: 30306271. Case report. ˍ




Marra JS, Mendes GP, Yoshinari GH Jr, da Silva Guimarães F, Mazin SC, de Oliveira HF.
Survival after radiation therapy for high-grade glioma.
Rep Pract Oncol Radiother. 2018 Oct 11, 2019;24(1):35-40. doi: 10.1016/j.rpor.2018.09.003. PMID: 30337846. Observational study. ˍ




Korja M, Raj R, Seppä K, Luostarinen T, Malila N, Seppälä M, Mäenpää H, Pitkäniemi J.
Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland.
Neuro Oncol. 2018 Oct 12, 2019;21(3):370-379. doi: 10.1093/neuonc/noy164. PMID: 30312433. Observational study. ˍ



*

Liu T, Xu H, Huang M, Ma W, Saxena D, Lustig RA, Alonso-Basanta M, Zhang Z, O Rourke DM, Zhang L, Gong Y, Kao GD, Dorsey JF, Fan Y.
Circulating glioma cells exhibit stem cell-like properties.
Cancer Res. 2018 Oct 15, 2018;78(23):6632-6642. doi: 10.1158/0008-5472.CAN-18-0650. PMID: 30322863. Laboratory investigation. ˍ




Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, Gupta N, Myseros JS, Hwang EI, Kline C, Crawford JR, Warren KE, Cha S, Liang WS, Berens ME, Packer RJ, Resnick AC, Prados M, Mueller S, Nazarian J.
Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
Clin Cancer Res. 2018 Oct 15, 2018;24(23):5850-5859. doi: 10.1158/1078-0432.CCR-18-1345. PMID: 30322880. Laboratory investigation. ˍ




Pérez-Beteta J, Molina-García D, Martínez-González A, Henares-Molina A, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, Martino J, Velásquez C, Meléndez-Asensio B, de Lope ÁR, Moreno R, Barcia JA, Asenjo B, Benavides M, Herruzo I, Lara PC, Cabrera R, Albillo D, Navarro M, Pérez-Romasanta LA, Revert A, Arana E, Pérez-García VM.
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Eur Radiol. 2018 Oct 15, 2019;29(4):1968-1977→. doi: 10.1007/s00330-018-5758-7. PMID: 30324390. Observational study. ˍ



*

Robins HI, Nguyen HN, Field A, Howard S, Salamat S, Deming DA.
Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide.
Front Oncol. 2018 Oct 15, 2018;8:451. doi: 10.3389/fonc.2018.00451. PMID: 30374424. Case report. ˍ




Hwang EI, Kool M, Burger PC, Capper D, Chavez L, Brabetz S, Williams-Hughes C, Billups C, Heier L, Jaju A, Michalski J, Li Y, Leary S, Zhou T, von Deimling A, Jones DTW, Fouladi M, Pollack IF, Gajjar A, Packer RJ, Pfister SM, Olson JM.
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.
J Clin Oncol. 2018 Oct 17, 2018;36(34):3388-3395. doi: 10.1200/JCO.2017.76.4720. PMID: 30332335. Interventional study. ˍ




Bin Abdulqader S, Al-Ajlan Z, Albakr A, Issawi W, Al-Bar M, Recinos PF, Alsaleh S, Ajlan A.
Endoscopic transnasal resection of optic pathway pilocytic astrocytoma.
Childs Nerv Syst. 2018 Oct 18, 2019;35(1):73-81. doi: 10.1007/s00381-018-3994-4. PMID: 30338361. Observational study. ˍ




Ahmadipour Y, Jabbarli R, Gembruch O, Pierscianek D, Oppong MD, Dammann P, Wrede K, Özkan N, Müller O, Sure U, El Hindy N.
Impact of multifocality and molecular markers on survival of glioblastoma.
World Neurosurg. 2018 Oct 19, 2019;122:e461-e466. doi: 10.1016/j.wneu.2018.10.075. PMID: 30347300. Observational study. ˍ




Sharma M, Schroeder JL, Elson P, Meola A, Barnett GH, Vogelbaum MV, Suh JH, Chao ST, Mohammadi AM, Stevens GHJ, Murphy ES, Angelov L.
Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
J Neurosurg. 2018 Oct 19,
2018;131(2):489-499. doi: 10.3171/2018.4.JNS172909. PMID: 30485180. Observational study. ˍ




van Dijken BRJ, van Laar PJ, Li C, Yan J-L, Boonzaier NR, Price SJ, van der Hoorn A.
Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
J Neurosurg. 2018 Oct 19, 2018;131(3):717-723. doi: 10.3171/2018.5.JNS18340. PMID: 30485234. Interventional study. ˍ




Guseynova K, Liscak R, Simonova G, Novotny J Jr.
Gamma knife radiosurgery for local recurrence of glioblastoma.
Neuro Endocrinol Lett. 2018 Oct 20, 2018;39(4):281-287. Electronic/Online ISSN: 2354-4716. PMID: 30531701. Observational study. ˍ




Reynaud T, Bertaut A, Farah W, Thibouw D, Crehange G, Truc G, Vulquin N.
Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Technol Cancer Res Treat. 2018 Oct 21, 2018;17:1533033818806498. doi: 10.1177/1533033818806498. PMID: 30343637. Observational study. ˍ




Cheung AT, Li WHC, Ho KY, Lam KKW, Ho LLK, Chiu SY, Chan GCF, Chung JOK.
Efficacy of musical training on psychological outcomes and quality of life in Chinese pediatric brain tumor survivors.
Psychooncology. 2018 Oct 23, 2019;28(1):174-180. doi: 10.1002/pon.4929. PMID: 30353603. Interventional study. ˍ




Foster E, McLean C, White O.
Glioneuronal brainstem tumor - It's all in the eyes.
J Clin Neurosci. 2018 Oct 23, 2019;60:151-153. doi: 10.1016/j.jocn.2018.10.084. PMID: 30366780. Case report. ˍ




Purkayastha A, Sharma N, Sridhar MS, Abhishek D.
Intramedullary Glioblastoma Multiforme of Spine with Intracranial Supratentorial Metastasis: Progressive Disease with a Multifocal Picture.
Asian J Neurosurg. 2018 Oct 23, 2018;13(4):1209-1212. doi: 10.4103/ajns.AJNS_67_17. PMID: 30459896. Case report. ˍ




Aasland D, Götzinger L, Hauck L, Berte N, Meyer J, Effenberger M, Schneider S, Reuber EE, Roos WP, Tomicic MT, Kaina B, Christmann M.
Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
Cancer Res. 2018 Oct 25, 2019;79(1):99-113. doi: 10.1158/0008-5472.CAN-18-1733. PMID: 30361254. Laboratory investigation. ˍ




Maraka S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, Conrad CA, Tremont-Lukats IW, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, de Groot JF, Alfred Yung WK, Penas-Prado M.
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
Cancer. 2018 Oct 25, 2019;125(3):424-433. doi: 10.1002/cncr.31811. PMID: 30359477. Interventional study. ˍ



*

Oh J, Kim Y, Baek D, Ha Y.
Malignant gliomas can be converted to non‑proliferating glial cells by treatment with a combination of small molecules.
Oncol Rep. 2018 Oct 25, 2019;41(1):361-368. doi: 10.3892/or.2018.6824. PMID: 30365111. Laboratory investigation. ˍ




Al-Husseini MJ, Saad AM, El-Shewy KM, Nissan NE, Gad MM, Alzuabi MA, Alfaar AS.
Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Int J Neurosci. 2018 Oct 26, 2019;129(5):447-454. doi: 10.1080/00207454.2018.1538989. PMID: 30366515. Observational study. ˍ




Jiang S, Eberhart CG, Lim M, Heo HY, Zhang Y, Blair L, Wen Z, Holdhoff M, Lin D, Huang P, Qin H, Quinones-Hinojosa A, Weingart JD, Barker PB, Pomper MG, Laterra J, van Zijl PCM, Blakeley JO, Zhou J.
Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy.
Clin Cancer Res. 2018 Oct 26, 2019;25(2):552-561. doi: 10.1158/1078-0432.CCR-18-1233. PMID: 30366937. Interventional study. ˍ




Kaur E, Goda JS, Ghorai A, Salunkhe S, Shetty P, Moiyadi AV, Sridhar E, Mahajan A, Jalali R, Dutt S.
Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short report.
Cell Oncol (Dordr). 2018 Oct 26, 2019;42(1):107-116. doi: 10.1007/s13402-018-0411-7. PMID: 30361826. Laboratory investigation. ˍ



*

Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, Strazzabosco M, Dalprà L, Lavitrano M, Bentivegna A.
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation.
Genes (Basel). 2018 Oct 26, 2018;9(11):522. doi: 10.3390/genes9110522. PMID: 30373123. Laboratory investigation. ˍ




Lee JH, Lee JH.
The origin-of-cell harboring cancer-driving mutations in human glioblastoma.
BMB Rep. 2018 Oct 31, 2018;51(10):481-483
. doi: 10.5483/BMBRep.2018.51.10.233. PMID: 30269745. Laboratory investigation. ˍ